Product Code: RP-ID-10013133 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013133
Market Overview:
Global Naloxone Market Size Study By Product (Spray Forms, and Injectable Forms), By Application (Opioid Overdose, and Preventing Opioid Abuse, and Others), and By Regional (North America, Europe, Asia Pacific, Latin America, and Rest of the World) Forecasts, 2018-2025
Global Naloxone Market to reach USD XXX million by 2025.
Global Naloxone Market valued approximately USD XXX million in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets rising availability of naloxone as a generic drug, and death cases from drug overdose increasing with alarmingly escalating rates. Continuous increase in prices of naloxone drug is a major constraint for the growth in market. Escalating engagement of private organizations and government in spreading cognizance regarding the availability of naloxone is a prime opportunity for growth in the market. Naloxone is a generic drug which is used to blocks or reverses the effects of opioid medication, including extreme drowsiness, slowed breathing, or loss of consciousness.
The regional analysis of Global Naloxone Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share. Furthermore, owing to countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate / CAGR over the forecast period 2018-2025.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
 Spray Forms
 Injectable Forms
By Application:
 Opioid Overdose
 Preventing Opioid Abuse
 Others
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Amphastar Pharmaceuticals, Pfizer, ADAPT Pharma, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals, Mylan, Angkor Data Communication Group Co., Ltd., Cybercomm, Route Mobile Limited, Infobip Ltd., Tyntec, Nexmo, DIMOCO and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Target Audience of the Naloxone Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Overview
Financial (Subject to Data Availability)
Product Summary
Pfizer
ADAPT Pharma
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Angkor Data Communication Group Co., Ltd.
Cybercomm
Route Mobile Limited
Infobip Ltd.
Tyntec
Nexmo
DIMOCO
Related Reports
Proof of Quality & Reliability
